Research Article
Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions
Table 1
Demographic and comorbidity details of patients.
| Patients | Height (cm) | Age (yr) | Body weight (kg) | History of psoriasis (yr) | Comorbid condition | Previous therapy |
| Patient 1 | 165.1 | 45 | 65 | 10 | Psoriatic arthritis | Emollient, cyclosporine, and methotrexate | Patient 2 | 162.6 | 62 | 75 | 11 | Type 2 diabetes with hypertension | Emollient and methotrexate | Patient 3 | 135.1 | 50 | 76 | 12 | Interstitial lung disease | Emollient, cyclosporine, and methotrexate | Patient 4 | 160.0 | 63 | 80 | 10 | Alcoholic liver disease | Emollient, cyclosporine, and methotrexate | Patient 5 | 135.1 | 35 | 60 | 6 | Hypertension | Emollient and methotrexate | Patient 6 | 170.2 | 35 | 65 | 8 | Hypertension | Emollient and methotrexate | Patient 7 | 152.4 | 59 | 67 | 13 | Type 2 diabetes with hypertension | Emollient and methotrexate |
|
|